Exome Asset Management’s Arbutus Biopharma ABUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$233K	Buy	+75,484	New	+$233K	0.17%	50
2025 Q1	–	Sell	-28,300	Closed	-$92.5K	–	50
2024 Q4	$92.5K	Buy	+28,300	New	+$92.5K	0.07%	58